Type 2 diabetes mellitus (T2DM) is a metabolic disease affecting an increasing percentage of general population worldwide. Patients with T2DM are frequently characterized by impaired renal function, primarily as a result of diabetic kidney injury, but also by other contributing factors, such as hypertension, atherosclerosis, and medications. Sodium-glucose cotransporter (SGLT)-2 inhibitors have emerged as a new, promising class of antidiabetic agents with actions that seem to extend beyond their hypoglycemic effect.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1002/cpt.731 | DOI Listing |
Publication Analysis
Top Keywords
sglt-2 inhibitors
8
renal effects
4
effects sglt-2
4
inhibitors anti-diabetic
4
anti-diabetic drugs
4
drugs clinical
4
clinical relevance
4
relevance potential
4
potential risks
4
risks type
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!